ALLOGENE THERAPEUTICS ANNOUNCES JOURNAL OF CLINICAL ONCOLOGY PUBLICATION OF PHASE 1 RESULTS OF ALLO-316 HIGHLIGHTING FIRST DURABLE REMISSIONS FOLLOWING ALLOGENEIC CAR T FOR TREATMENT OF METASTATIC SOLID TUMORS

Reuters · 3d ago

Please log in to view news